1. |
Griffith TS,Chin WA,Jackson GC,et al. Intracellular regulation of TRAILinduced apoptosis in human melanoma cells[J].J Immunol,1998,161(6):2833-2840..
|
2. |
Wiley SR,Schooley K,Smolak PJ,et al.Indentification and characterization of a new member of the TNF family that induces apoptosis[J].Immunity,1995,3(6):673-682..
|
3. |
Sheridan JP,Marsters SA,Pitti RM,et al.Control of TRAILinduced apoptosis by a family of signaling and decoy receptors[J].Science,1997,277(5327):818-821..
|
4. |
Sprick MR,Weigand MA,Rieser E,et al.FADD/MORT1 and caspase8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2[J].Immunity,2000,12(6):599-609..
|
5. |
Thomas LR,Henson A,Reed JC,et al.Direct binding of Fasassociated death domain (FADD) to the tumor necrosis factorrelated apoptosisinducing ligand receptor DR5 is regulated by the death effector domain of FADD[J].J Biol Chem,2004,279(31):32780-32785..
|
6. |
李春梅,彭芝兰,尹如铁.TRAIL蛋白对卵巢癌COC1和COC1/DDP细胞生长及促凋亡作用研究[J].四川肿瘤防治,2006,19(3):161-166..
|
7. |
Cuello M,Ettenberg SA,Nau MM,et al.Synergistic induction of apoptosis by the combination of TRAIL and chemotherapy in chemoresistant ovarian cancer cells[J].Gynecol Oncol,2001,81(3):380-390..
|
8. |
Arts HJ,de Jong S,Hollema H,et al.Chemotherapy induces death receptor 5 in epithelial ovarian carcinoma[J].Gynecol Oncol,2004,92(3):794-800..
|
9. |
Tomek S,Horak P,Pribill I,et al.Resistance to TRAILinduced apoptosis in ovarian cancer cell lines is overcome by cotreatment with cytotoxic drugs[J].Gynecol Oncol,2004,94(1):107-114..
|